RMD
ResMed·NYSE
--
--(--)
--
--(--)
RMD fundamentals
ResMed (RMD) Revenue Breakdown: Q2 2026 Business & Regional Performance
ResMed (RMD) reported total revenue of 1.42B USD in Q2 2026, with its core business segment Sleep and Respiratory Care contributing 88.27%. Regionally, United States, Canada and Latin America remained the largest market, accounting for 66.49% of total revenue. Explore ResMed's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
ResMed (RMD) reported total revenue of 1.42B USD in Q2 2026, with its core business segment Sleep and Respiratory Care contributing 88.27%. Regionally, United States, Canada and Latin America remained the largest market, accounting for 66.49% of total revenue. Explore ResMed's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from ResMed’s earnings call?What factors drove the changes in ResMed's revenue and profit?What guidance did ResMed's management provide for the next earnings period?What is the revenue and EPS growth rate for ResMed year over year?What is ResMed's gross profit margin?What does ResMed do and what are its main business segments?Did ResMed beat or miss consensus estimates last quarter?What is ResMed's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
